Morgan Stanley China A Share Fund, Inc.

NYSE:CAF

12.8 (USD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152010
Revenue -44.703-131.363-12.26162.66389.45-108.741189.055-15.182219.2040
Cost of Revenue 5.6676.9729.2459.2088.9279.9049.4758.11114.050
Gross Profit -50.37-138.335-21.50653.45580.523-118.645179.58-23.293205.1540
Gross Profit Ratio 1.1271.0531.7540.8530.91.0910.951.5340.9360
Reseach & Development Expenses 00-00000000
General & Administrative Expenses 1.0241.1691.2691.3121.2591.3161.429000
Selling & Marketing Expenses 0000000000
SG&A 1.0241.1691.2691.3121.2591.3161.429000
Other Expenses 00.0110.010.0130.0070.002-0.001-16.78-156.9930
Operating Expenses -44.7031.181.2791.3251.2661.3181.428-16.78156.9930
Operating Income -46.134-132.543-13.5461.33888.184-110.059187.627-40.07348.1610
Operating Income Ratio 1.0321.0091.1040.9790.9861.0120.9922.640.220
Total Other Income Expenses Net 0.396000000-1.409-1.8950
Income Before Tax -45.738-132.543-13.5461.33888.184-110.059187.627-41.48246.2660
Income Before Tax Ratio 1.0231.0091.1040.9790.9861.0120.9922.7320.2110
Income Tax Expense 0-4.0810.0231.041-0.654-0.1610.789000
Net Income -45.738-132.543-13.5461.33888.184-110.059187.627-41.48246.2660
Net Income Ratio 1.0231.0091.1040.9790.9861.0120.9922.7320.2110
EPS -2.11-6.06-0.622.84.03-5.038.57-1.92.110
EPS Diluted -2.11-6.06-0.622.84.03-5.038.57-1.92.110
EBITDA -46.134-132.543-13.5461.33888.184-110.059187.627-40.07348.1610
EBITDA Ratio 1.0321.0091.1040.9790.9861.0120.9922.640.220